We also compared the CLL-accessible regions with epigenome segmentations for CD19+ B cells (Fig. 1e and Supplementary Fig. 4c), a related cell type for which comprehensive reference epigenome data are publicly available28. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.